US 11746152
Methods of cancer treatment and therapy using a combination of antibodies that bind glycosylated PD-L1
granted A61KA61K2039/507A61P
Quick answer
US patent 11746152 (Methods of cancer treatment and therapy using a combination of antibodies that bind glycosylated PD-L1) held by The Board of Regents of the University of Texas System expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Sep 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/507, A61P, A61P35/00